Emerging role of TAK1 in the regulation of skeletal muscle mass

被引:2
|
作者
Roy, Anirban [1 ]
Narkar, Vihang A. [2 ]
Kumar, Ashok [1 ,3 ]
机构
[1] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX USA
[2] Univ Texas Hlth Sci Ctr, Brown Fdn Inst Mol Med, McGovern Med Sch, Houston, TX USA
[3] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Hlth Bldg 2,Room 5012, Houston, TX 77204 USA
基金
美国国家卫生研究院;
关键词
hypertrophy; neuromuscular junctions; protein synthesis; signaling; skeletal muscle atrophy; TAK1; ACTIVATED KINASE 1; NF-KAPPA-B; TGF-BETA; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; INDEPENDENT ACTIVATION; SIGNALING PATHWAYS; OXIDATIVE STRESS; MESSENGER-RNA; UP-REGULATION;
D O I
10.1002/bies.202300003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Maintenance of skeletal muscle mass and strength throughout life is crucial for heathy living and longevity. Several signaling pathways have been implicated in the regulation of skeletal muscle mass in adults. TGF-beta-activated kinase 1 (TAK1) is a key protein, which coordinates the activation of multiple signaling pathways. Recently, it was discovered that TAK1 is essential for the maintenance of skeletal muscle mass and myofiber hypertrophy following mechanical overload. Forced activation of TAK1 in skeletal muscle causes hypertrophy and attenuates denervation-induced muscle atrophy. TAK1-mediated signaling in skeletal muscle promotes protein synthesis, redox homeostasis, mitochondrial health, and integrity of neuromuscular junctions. In this article, we have reviewed the role and potential mechanisms through which TAK1 regulates skeletal muscle mass and growth. We have also proposed future areas of research that could be instrumental in exploring TAK1 as therapeutic target for improving muscle mass in various catabolic conditions and diseases.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Targeting of TAK1 in inflammatory disorders and cancer
    Sakurai, Hiroaki
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (10) : 522 - 530
  • [22] Multifaceted roles of TAK1 signaling in cancer
    Mukhopadhyay, Himadri
    Lee, Nam Y.
    ONCOGENE, 2020, 39 (07) : 1402 - 1413
  • [23] Role of mTORC1 in mechanically induced increases in translation and skeletal muscle mass
    Goodman, Craig A.
    JOURNAL OF APPLIED PHYSIOLOGY, 2019, 127 (02) : 581 - 590
  • [24] Emerging role of MyomiRs as biomarkers and therapeutic targets in skeletal muscle diseases
    Srivastava, Sukanya
    Rathor, Richa
    Singh, Som Nath
    Suryakumar, Geetha
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 321 (05): : C859 - C875
  • [25] Tit for TAK1 Reciprocal Regulation of Inflammasome Signaling in Cardiac Hypertrophy
    Dundas, Jameson A.
    Deniset, Justin F.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (12): : 1574 - 1576
  • [26] TAK1 regulates hepatic cell survival and carcinogenesis
    Roh, Yoon Seok
    Song, Jingyi
    Seki, Ekihiro
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (02) : 185 - 194
  • [27] TAK1 control of cell death
    Mihaly, S. R.
    Ninomiya-Tsuji, J.
    Morioka, S.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (11) : 1667 - 1676
  • [28] Regulation of REDD1 by Insulin-Like Growth Factor-I in Skeletal Muscle and Myotubes
    Frost, Robert A.
    Huber, Danuta
    Pruznak, Anne
    Lang, Charles H.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (05) : 1192 - 1202
  • [29] TAK1, more than just innate immunity
    Dai, Liang
    Thu, Chan Aye
    Liu, Xin-Yu
    Xi, Jiajia
    Cheung, Peter C. F.
    IUBMB LIFE, 2012, 64 (10) : 825 - 834
  • [30] TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma
    Campolo, Michela
    Lanza, Marika
    Casili, Giovanna
    Paterniti, Irene
    Filippone, Alessia
    Caffo, Maria
    Cardali, Salvatore M.
    Puliafito, Ivana
    Colarossi, Cristina
    Raciti, Gabriele
    Cuzzocrea, Salvatore
    Esposito, Emanuela
    CANCERS, 2021, 13 (01) : 1 - 17